CNBC’s “Money Movers”

Money Movers+ Novo Nordisk CEO Lars Fruergaard Jorgensen 3/8/24

Episode Summary

Novo Nordisk president and CEO Lars Fruergaard Jørgensen joins CNBC's Sara Eisen to discuss the company’s latest trial results, how they fit into the weight-loss medicine landscape, and the supply-demand picture for Novo Nordisk’s products.